What are the benefits of taking part in the study?
Participants may be helping themselves, but it is expected that the information from this study may help doctors and scientists to improve treatment for people who have kidney disease. If empagliflozin is shown to have benefits, results from this study may help to prevent deaths from heart disease and the need for dialysis or transplantation around the world.
Please note that participants are donating their time, information and blood/urine samples, for which we are grateful, but they or their relatives will not be able to receive any financial benefits from any discoveries or products developed using the results from this study or any future research using their health information and data.